US Patent Issued to UNIVERSITE LAVAL on Aug. 5 for "CRISPR-cas9 system and uses thereof" (Canadian Inventor)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,378,549, issued on Aug. 5, was assigned to UNIVERSITE LAVAL (Quebec, Canada).

"CRISPR-cas9 system and uses thereof" was invented by Yannick Doyon (Quebec, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods and products are described herein for the modification of nucleic acids using a CRISPR/Cas9 system. Also described herein are uses of such methods and products for the modification of a target nucleic acid in a cell, in vitro or in vivo. Such methods and products may also be used for prevention or treatment of a condition associated with a target polynucleotide."

The patent was filed on May 10, 2019, under Application No. 17/054,008.

*For ...